Article

Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities

Journal of the European Academy of Dermatology and Venereology
DOI: 10.1111/jdv.17229
20Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

De, D., Kaushik, A., Handa, S., Mahajan, R., & Schmidt, E. (2021, July 1). Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities. Journal of the European Academy of Dermatology and Venereology. John Wiley and Sons Inc. https://doi.org/10.1111/jdv.17229

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free